Detalles de la búsqueda
1.
Patterns of Recurrence After Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation.
Ann Surg Oncol
; 31(1): 413-420, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37755563
2.
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
Oncologist
; 28(9): 827-e822, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104870
3.
Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.
Ann Surg Oncol
; 30(6): 3479-3488, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36792768
4.
Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Oncologist
; 27(6): 447-452, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641196
5.
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Invest New Drugs
; 40(6): 1306-1314, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264382
6.
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.
Lancet Oncol
; 22(1): 118-131, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387490
7.
Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study.
Ann Surg
; 274(6): e1153-e1161, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31913871
8.
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Int J Cancer
; 146(5): 1316-1323, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31509608
9.
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy.
Oncologist
; 25(8): 669-679, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31943525
10.
Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Oncologist
; 24(4): 463-474, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355775
11.
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
N Engl J Med
; 374(3): 211-22, 2016 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26789870
12.
ASO Visual Abstract: Patterns of Recurrence after Poor Response to Neoadjuvant Chemotherapy in Gastric Cancer and the Role for Adjuvant Radiation.
Ann Surg Oncol
; 31(2): 817, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875741
13.
Pancreatic Adenocarcinoma, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 202-210, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30865919
14.
Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.
HPB (Oxford)
; 21(7): 883-890, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723062
15.
Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study.
Oncologist
; 23(1): 16-24, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038234
16.
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med
; 372(26): 2509-20, 2015 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26028255
17.
Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.
Ann Surg Oncol
; 25(7): 1880-1888, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29667116
18.
LANREOTIDE THERAPY IN CARCINOID SYNDROME: PROSPECTIVE ANALYSIS OF PATIENT-REPORTED SYMPTOMS IN PATIENTS RESPONSIVE TO PRIOR OCTREOTIDE THERAPY AND PATIENTS NAÏVE TO SOMATOSTATIN ANALOGUE THERAPY IN THE ELECT PHASE 3 STUDY.
Endocr Pract
; 24(3): 243-255, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29547049
19.
BIOCHEMICAL RESPONSES IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH NEUROENDOCRINE TUMORS: POOLED ANALYSIS OF 2 PHASE 3 TRIALS.
Endocr Pract
; 2018 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084687
20.
Importance of surgeons in cooperative groups: Perspectives from the medical oncologists.
J Surg Oncol
; 125(1): 93-94, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897712